Therapy News and Research

RSS

Immune checkpoint protein may be a promising new target for prostate cancer immunotherapy

The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers, according to two new studies led by researchers at the Johns Hopkins Kimmel Cancer Center.

2 Nov 2021

Understanding the current medical landscape of prostate cancer

In this interview, News-Medical talks to Dr. Simon Chowdhury and Laetitia Guilloux about the current state of prostate cancer, it's prevalence, treatment options and its future.

From Janssen Pharmaceuticals 2 Nov 2021

SARS-CoV-2 variants neutralized by camel nanobodies

Researchers from the US recently isolated two VHH nanobodies - 7A3 and 8A2 - from dromedary camels (Camelus dromedaries) using phage display. These nanobodies were found to have a high affinity for the spike RBD and broad neutralization abilities against SARS-CoV-2 and its variants.

2 Nov 2021

Art therapy and teaching through art can contribute to wellbeing of students

The doctoral dissertation focuses on school factors that affect the subjective wellbeing of school-aged children and how art can contribute to the wellbeing of students.

1 Nov 2021

Researchers develop a new test to more easily diagnose medulloblastoma

Researchers at the University of British Columbia and BC Cancer, in partnership with BC Children's Hospital Research Institute, have developed a new test to more easily diagnose medulloblastoma, the most common malignant childhood brain tumor.

1 Nov 2021

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Scientists explore the link between SARS-CoV-2 infection and anti-NMDAR encephalitis.

1 Nov 2021

Identification of novel nanobodies to specifically target SARS-CoV-2 replication protein

Researchers have recently identified two nanobodies that show specific binding against a SARS-CoV-2 replication protein.

1 Nov 2021

Researchers generate and characterize the hepatic organoid culture system

Organoid technologies have become a powerful emerging tool to model liver diseases, for drug screening, and for personalized treatments.

1 Nov 2021

$Non-thermal atmospheric pressure plasma heals bone fractures in animal bone defect models$

Non-thermal atmospheric pressure plasma heals bone fractures in animal bone defect models

Recent technological innovations which have allowed plasma to be generated at room temperature and at ambient atmosphere in what is called non-thermal atmospheric pressure plasma (NTAPP) have given scientists from Japan the opportunity to apply the therapeutic properties of this "fourth state of matter" to bone regeneration.

1 Nov 2021

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

A recent study published in the journal Cellular & Molecular Immunology shows that a new A.30 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can evade vaccine-induced antibodies and might spread outside the lungs extraordinarily well, with important implications for our public health response.

1 Nov 2021

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

A new type of magnetic brain stimulation brought rapid remission to almost 80% of participants with severe depression in a study conducted at the Stanford University School of Medicine.

30 Oct 2021

World-renowned expert to lead pediatric cardiology division at Washington University School of Medicine

Andrew C. Glatz, MD, an internationally recognized expert in pediatric interventional cardiology, has been selected to lead the Division of Pediatric Cardiology in the Department of Pediatrics at Washington University School of Medicine in St. Louis.

30 Oct 2021

Harnessing the genetics of hookworms to develop next generation of PPE for combat troops

Researchers at Washington University School of Medicine in St. Louis have received a grant to develop the next generation of personal protective equipment (PPE) for combat troops.

30 Oct 2021

New EcoTyper tool can help identify cancer subtypes

Researchers at the Stanford Institute for Stem Cell Biology and Regenerative Medicine have devised a tool to examine how cells behave and interact in various environments of the body.

30 Oct 2021

Two new studies show how to enhance effectiveness of cancer immunotherapy

Two new studies revealed that anti-PD-1 immunotherapy given before surgery was safe and effective for patients with oral-cavity squamous cell carcinoma (OCSCC) and identified potential molecular biomarkers in the blood and tumors of patients that would show how likely it is that someone would respond to immunotherapy.

30 Oct 2021

Researchers decipher when and why T cells become non-responsive to immunotherapy

Non-small cell lung cancer is the most common type of lung cancer in humans. Some patients with NSCLC receive a therapy called immune checkpoint blockade (ICB) that helps kill cancer cells by reinvigorating a subset of immune cells called T cells, which are "exhausted" and have stopped working.

30 Oct 2021

Therapeutic heparin for preventing COVID-19 deaths is four times higher than the prophylactic dose

The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according to a study reported on October 14 in the British Medical Journal.

30 Oct 2021

Therapy News and Research

Immune checkpoint protein may be a promising new target for prostate cancer immunotherapy

Understanding the current medical landscape of prostate cancer

SARS-CoV-2 variants neutralized by camel nanobodies

Art therapy and teaching through art can contribute to wellbeing of students

Researchers develop a new test to more easily diagnose medulloblastoma

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Identification of novel nanobodies to specifically target SARS-CoV-2 replication protein

Researchers generate and characterize the hepatic organoid culture system

Non-thermal atmospheric pressure plasma heals bone fractures in animal bone defect models

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

World-renowned expert to lead pediatric cardiology division at Washington University School of Medicine

Harnessing the genetics of hookworms to develop next generation of PPE for combat troops

New EcoTyper tool can help identify cancer subtypes

Two new studies show how to enhance effectiveness of cancer immunotherapy

Researchers decipher when and why T cells become non-responsive to immunotherapy

Therapeutic heparin for preventing COVID-19 deaths is four times higher than the prophylactic dose

Researchers discover potential new Covid-19 treatment

New project investigates stem cell therapy as a potential treatment for glaucoma

Researchers develop eToeholds for safe, effective RNA and cellular therapies

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News